tiprankstipranks
GlaxoSmithKline (GSK)
NYSE:GSK
US Market
GSK
GlaxoSmithKline
RESEARCH TOOLSreports
Want to see GSK full AI Analyst Report?

GlaxoSmithKline (GSK) Ratios

5,227 Followers

GlaxoSmithKline Ratios

GSK's free cash flow for Q1 2026 was £―. For the 2026 fiscal year, GSK's free cash flow was decreased by £ and operating cash flow was £―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.82 0.82 0.78 0.88 0.91
Quick Ratio
 0.54 0.54 0.52 0.62 0.68
Cash Ratio
 0.16 0.16 0.17 0.14 0.16
Solvency Ratio
 0.21 0.21 0.11 0.12 0.34
Operating Cash Flow Ratio
 0.35 0.33 0.30 0.29 0.36
Short-Term Operating Cash Flow Coverage
 2.51 2.38 3.01 2.20 2.16
Net Current Asset Value
£ -27.65B£ -27.54B£ -29.38B£ -35.14B£ -29.28B
Leverage Ratios
Debt-to-Assets Ratio
 0.29 0.29 0.29 0.31 0.35
Debt-to-Equity Ratio
 1.08 1.08 1.24 1.35 1.98
Debt-to-Capital Ratio
 0.52 0.52 0.55 0.57 0.66
Long-Term Debt-to-Capital Ratio
 0.47 0.47 0.50 0.51 0.60
Financial Leverage Ratio
 3.73 3.73 4.35 4.42 5.68
Debt Service Coverage Ratio
 2.90 2.85 2.16 1.91 1.70
Interest Coverage Ratio
 10.23 10.23 6.11 8.70 7.52
Debt to Market Cap
 0.22 0.24 0.29 0.37 0.34
Interest Debt Per Share
 4.58 9.07 8.66 11.72 10.85
Net Debt to EBITDA
 1.23 1.23 1.99 2.12 2.01
Profitability Margins
Gross Profit Margin
72.49%72.54%71.16%71.76%67.42%
EBIT Margin
24.82%24.81%13.12%22.39%22.01%
EBITDA Margin
36.38%36.38%21.25%29.95%29.33%
Operating Profit Margin
21.95%21.95%12.82%22.24%21.94%
Pretax Profit Margin
22.66%22.66%11.08%19.99%19.19%
Net Profit Margin
17.50%17.50%8.21%16.25%51.00%
Continuous Operations Profit Margin
19.25%19.25%9.41%17.50%16.78%
Net Income Per EBT
77.23%77.23%74.06%81.27%265.74%
EBT Per EBIT
103.24%103.24%86.47%89.90%87.49%
Return on Assets (ROA)
9.35%9.16%4.33%6.55%24.87%
Return on Equity (ROE)
37.19%34.20%18.84%28.96%141.12%
Return on Capital Employed (ROCE)
18.05%17.68%10.65%13.95%17.23%
Return on Invested Capital (ROIC)
14.25%13.97%8.51%11.37%13.62%
Return on Tangible Assets
15.30%14.99%6.97%10.33%38.56%
Earnings Yield
7.42%7.58%4.67%8.35%25.58%
Efficiency Ratios
Receivables Turnover
 4.21 4.13 5.23 3.21 4.72
Payables Turnover
 0.58 0.57 2.61 1.81 2.47
Inventory Turnover
 1.52 1.48 1.60 1.22 1.86
Fixed Asset Turnover
 3.25 3.19 3.11 2.39 3.05
Asset Turnover
 0.53 0.52 0.53 0.40 0.49
Working Capital Turnover Ratio
 -8.86 -7.45 -8.06 -11.82 -6.66
Cash Conversion Cycle
 170.48 -304.31 158.82 210.33 126.30
Days of Sales Outstanding
 73.46 88.48 69.79 113.58 77.40
Days of Inventory Outstanding
 240.57 246.05 228.69 298.68 196.60
Days of Payables Outstanding
 143.56 638.84 139.66 201.93 147.70
Operating Cycle
 314.04 334.53 298.48 412.26 273.99
Cash Flow Ratios
Operating Cash Flow Per Share
 1.88 3.53 3.22 3.89 4.05
Free Cash Flow Per Share
 1.25 2.88 1.75 3.09 3.35
CapEx Per Share
 0.63 0.65 1.46 0.81 0.70
Free Cash Flow to Operating Cash Flow
 0.66 0.82 0.55 0.79 0.83
Dividend Paid and CapEx Coverage Ratio
 1.48 1.87 1.21 1.78 1.44
Capital Expenditure Coverage Ratio
 2.98 5.42 2.20 4.83 5.80
Operating Cash Flow Coverage Ratio
 0.43 0.40 0.39 0.34 0.39
Operating Cash Flow to Sales Ratio
 0.23 0.22 0.21 0.26 0.28
Free Cash Flow Yield
6.56%7.90%6.48%10.60%11.55%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 14.20 13.19 21.39 11.98 3.91
Price-to-Sales (P/S) Ratio
 2.47 2.31 1.76 1.95 1.99
Price-to-Book (P/B) Ratio
 4.96 4.51 4.03 3.47 5.52
Price-to-Free Cash Flow (P/FCF) Ratio
 16.07 12.66 15.42 9.43 8.66
Price-to-Operating Cash Flow Ratio
 10.75 10.32 8.41 7.48 7.17
Price-to-Earnings Growth (PEG) Ratio
 0.11 0.11 -0.44 0.00 -0.36
Price-to-Fair Value
 4.96 4.51 4.03 3.47 5.52
Enterprise Value Multiple
 7.99 7.57 10.26 8.62 8.81
Enterprise Value
 91.14B 88.02B 68.38B 78.26B 75.74B
EV to EBITDA
 7.67 7.57 10.26 8.62 8.81
EV to Sales
 2.79 2.75 2.18 2.58 2.58
EV to Free Cash Flow
 18.15 15.11 19.14 12.51 11.22
EV to Operating Cash Flow
 12.07 12.32 10.43 9.92 9.28
Tangible Book Value Per Share
 -1.93 -3.82 -4.62 -5.53 -5.60
Shareholders’ Equity Per Share
 4.07 8.07 6.71 8.40 5.26
Tax and Other Ratios
Effective Tax Rate
 0.15 0.15 0.15 0.12 0.13
Revenue Per Share
 8.13 15.77 15.39 14.97 14.57
Net Income Per Share
 1.42 2.76 1.26 2.43 7.43
Tax Burden
 0.77 0.77 0.74 0.81 2.66
Interest Burden
 0.91 0.91 0.84 0.89 0.87
Research & Development to Revenue
 0.23 0.23 0.20 0.21 0.19
SG&A to Revenue
 0.28 0.28 0.35 0.31 0.29
Stock-Based Compensation to Revenue
 0.00 0.00 0.01 0.00 0.00
Income Quality
 1.22 1.28 2.22 1.29 1.49
Currency in GBP